Cargando…
Notch signaling and non-small cell lung cancer
Lung cancer is the leading cause of cancer-associated mortality worldwide. Elucidation of the pathogenesis and biology of lung cancer is critical for the design of an effective treatment for patients. Non-small cell lung cancer (NSCLC) accounts for 80–85% of lung cancer cases. The abnormal expressio...
Autores principales: | Zou, Bin, Zhou, Xue-Liang, Lai, Song-Qing, Liu, Ji-Chun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5796339/ https://www.ncbi.nlm.nih.gov/pubmed/29467866 http://dx.doi.org/10.3892/ol.2018.7738 |
Ejemplares similares
-
Notch Transduction in Non-Small Cell Lung Cancer
por: Sharif, Amnah, et al.
Publicado: (2020) -
Non-small-cell lung carcinoma: role of the Notch signaling pathway
por: Barse, Levi, et al.
Publicado: (2015) -
Epidermal growth factor receptor and notch signaling in non‐small‐cell lung cancer
por: Pancewicz‐Wojtkiewicz, Joanna
Publicado: (2016) -
Gambogic Acid Induces Apoptosis of Non-Small Cell Lung Cancer (NSCLC) Cells by Suppressing Notch Signaling
por: Zhu, Minghua, et al.
Publicado: (2018) -
Notch signaling and EMT in non-small cell lung cancer: biological significance and therapeutic application
por: Yuan, Xun, et al.
Publicado: (2014)